Role of antiviral prophylaxis in renal transplant recipients at high risk of cytomegalovirus infection

Journal of Clinical Virology

Volumn 42, Issue 3, 2008, Pages 293-294

  Costa, Cristina ^a   Bergallo, Massimiliano ^a   Cavallo, Rossana ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antigenemia; Cytomegalovirus; Prophylaxis; Renal transplantation

Indexed keywords

GANCICLOVIR;

CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; LETTER; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CHEMOPREVENTION; CYTOMEGALOVIRUS INFECTIONS; HUMANS; TRANSPLANTATION;

EID: 45449099241     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.001     Document Type: Letter

References (4)

1. Baillie G.M. Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy. Am J Health-Syst Pharm 63 Suppl. 5 (2006) S10-S16
2. Gerna G., Lilleri D., Fornara C., Comolli G., Lozza L., Campana C., Pellegrini C., Meloni F., and Rampino T. Monitoring of human citomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation. Am J Transplant 6 (2006) 2356-2364
3. Hughes D., Hafferty J., Fulton L., Friend P., Devaney A., Loke J., Welsh K.I., Handa A., and Klenerman P. Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients. J Clin Virol 41 (2008) 92-95
4. Razonable R.R. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health-Syst Pharm 62 Suppl. 1 (2005) S7-S13